CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MIRACLE project aims to enhance the prediction of atherosclerotic cardiovascular disease (ASCVD) by integrating genetic data and biomarkers. It focuses on developing advanced models that account for genetic risk factors and individual disease mechanisms to improve early diagnosis and treatment of conditions like st…
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality worldwide.
Aside from asymptomatic manifestations, the first sign of clinically significant ASCVD is often a severe clinical event, such as stroke or myocardial infarction (MI).
Thus, identifying individuals at high risk is crucial in preventing the fatal consequences of ASCVD.
Current risk prediction models based on traditional risk factors, such as SCORE2, have limitations since they do not encompass all mechanism…
UNIVERSITY OF EASTERN FINLAND (UEF)
ITA-SUOMEN YLIOPISTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Munich
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Munchen
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
